China Biologic Produ (CBPO) Stock News
NASDAQ:CBPO - Nasdaq -
CBPO Latest News, Press Relases and Analysis
China Biologic Privatization Transaction Led by Centurium Capital Wins AVCJ "Deal of the Year - Large Cap"
/PRNewswire/ -- The Centurium Capital-led privatization of leading plasma-based biopharmaceutical company China Biologic Products Holdings Inc. ("China...
The Daily Biotech Pulse: Moderna To Supply Variant-Specific Vaccine To Israel, Roche's Diagnostics Business Comes to Rescue
Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech Stocks Hitting 52-week Highs April 20) Alexion Pharmaceuticals,...
Stocks That Hit 52-Week Highs On Friday
This morning 230 companies reached new 52-week highs. Interesting Points: The largest company by market cap to set a new 52-week high was Tesla (NASDAQ: TSLA). Live...
China Biologic Announces Completion of Going Private Transaction
China Biologic Reports Financial Results for the Fourth Quarter and Fiscal Year 2020
BEIJING, March 29, 2021 /PRNewswire/ -- China Biologic Products Holdings, Inc. (NASDAQ: CBPO, 'China Biologic' or the 'Company'), a leading fully ...
China Biologic Reports Financial Results for the Fourth Quarter and Fiscal Year 2020
China Biologic Announces Shareholders' Approval of Merger Agreement
China Biologic Announces Extraordinary General Meeting of Shareholders
China Biologic Products Inc (CBPO) Q3 2020 Earnings Call Transcript
CBPO earnings call for the period ending September 30, 2020.
China Biologic Reports Financial Results for the Third Quarter of 2020
BEIJING, Nov. 24, 2020 /PRNewswire/ -- China Biologic Products Holdings, Inc. (NASDAQ: CBPO, 'China Biologic' or the 'Company'), a leading fully i...
China Biologic Reports Financial Results for the Third Quarter of 2020
China Biologic Enters into Definitive Merger Agreement for Going Private Transaction
China Biologic Products to Report Third Quarter 2020 Financial Results
BEIJING, Nov. 13, 2020 /PRNewswire/ -- China Biologic Products Holdings, Inc. (NASDAQ: CBPO) ('China Biologic' or the 'Company'), a leading fully ...
China Biologic Products to Report Third Quarter 2020 Financial Results
China Biologic Products Inc (CBPO) Q2 2020 Earnings Call Transcript
CBPO earnings call for the period ending June 30, 2020.
Update on China Biologic Products Q2 earnings (NASDAQ:CBPO)
China Biologic Products (CBPO -1.9%) Q2 reports total sales of $111.1M (-18.1% Y/Y).Gross profit decreased by 16.0% to $76.4M.Income from operations decreased by 11.4% to $42.7M from $48.2M last year.Non-GAAP adjusted net income decreased 10.9% to $43.4M.Non-GAAP EPS of $1.11, misses consensus.In April 2020, the company received approval from the Health Commission of Shandong Province to build a new plasma collection station in Yangxin County, Binzhou City of Shandong Province.Previously: China Biologic Products EPS misses by $0.17 (Aug.
China Biologic Reports Financial Results for the Second Quarter of 2020
BEIJING, Aug. 17, 2020 /PRNewswire/ -- China Biologic Products Holdings, Inc. (NASDAQ: CBPO, 'China Biologic' or the 'Company'), a leading fully i...
China Biologic Products EPS misses by $0.17 (NASDAQ:CBPO)
China Biologic Products (NASDAQ:CBPO): Q2 Non-GAAP EPS of $1.11 misses by $0.17; GAAP EPS of $0.91.Revenue of $111.1M (-18.1% Y/Y)Press Release
China Biologic Reports Financial Results for the Second Quarter of 2020
China Biologic Products to Report Second Quarter 2020 Financial Results
Best & Worst Performing Mid Cap Stocks for June 29, 2020
PCRX – PCRX leads the way today as the best performing mid cap stock, closing up 17.99%.
China Biologic Provides Additional Comments on the Xinjiang Deyuan and Shuanglin Transaction
China Inc. Pulls Out of U.S. Market at Fastest Pace Since 2015
Chinese companies are ditching their U.S. listings at the fastest pace since 2015 as they grapple with rising tensions between Beijing and Washington.
Best & Worst Performing Mid Cap Stocks for June 11, 2020
RETA – RETA leads the way today as the best performing mid cap stock, closing up 28.08%.
